Growth across the U.S. infusion therapy device space remains uneven in 2025 as providers balance rising procedure volumes with tighter budgets. Established consumables such as IV sets still dominate by value, yet newer technologies and alternate care settings are shifting where and how growth occurs. At the same time, safety concerns, recalls and pricing pressure continue to shape purchasing decisions. This creates a mixed landscape where some device types accelerate while others slow down.
Find growth niches in minutes, not months.
Explore quick, actionable insights from the select markets.
Table of Contents
➜ Where the fastest growing infusion therapy device markets are emerging
➜ Why infusion pumps show mixed but meaningful growth
➜ How needleless connector trends are changing market value
➜ What drives faster growth in blood warmers and transfusion devices
➜ How to apply these insights in strategy
➜ Conclusion and next steps for healthcare market research
Key Takeaways
- Blood warmers show the fastest projected growth, driven by procedure stability and value-added warming technology.
- Smart pump features such as wireless connectivity continue to lift ASPs despite limited unit gains.
- Neutral displacement NLCs grow faster than older connector types due to safety and reflux concerns.
- Alternate care sites expand device demand as home infusion increases.
- Product recalls and adverse events slow some pump and connector categories.
Where the fastest growing infusion therapy device markets are emerging
Across all infusion therapy categories, the most notable acceleration appears in blood warmers and related transfusion products. These devices track steady transfusion procedure volumes and benefit from added safety and performance features that support higher pricing. Growth also reflects shifts toward consistent warming protocols in emergency and surgical care. IV sets remain the largest segment by value, but their growth trails faster-moving categories because volume is stable and pricing is competitive. Taken together, the market shows steady expansion but with clear pockets of outperformance.
👉 For complete forecasts, procedure volumes, and competitor shares, see the:
Why infusion pumps show mixed but meaningful growth
Infusion pumps remain a high-value segment, but the growth rate varies by pump type. Large-volume and syringe pumps expand slowly because they are replacement-driven and heavily standardized. However, smart pump platforms with EMR auto-programming and drug libraries keep ASPs rising. One of the headline trends is the higher refresh rate created by software-linked support cycles, which encourages more frequent pump fleet upgrades. Electronic ambulatory pumps also gain share as a lower-cost alternative, while disposable ambulatory pumps grow more slowly due to drug-based competition. The result is steady but not rapid expansion compared with top-performing categories.
How needleless connector trends are changing market value
Neutral displacement NLCs remain one of the more dynamic subsegments. These connectors carry higher ASPs as facilities shift away from positive displacement valves, which have been linked to higher CRBSI rates. Although neutral designs still show minimal negative displacement, the reduced reflux profile supports strong adoption. Their premium pricing contributes to market value even as unit growth remains modest. At the same time, some facilities move toward lower-cost split septum connectors due to contamination concerns and sterilization challenges with mechanical valves. The net effect is mixed but still stronger growth compared with IV sets.
What drives faster growth in blood warmers and transfusion devices
Blood warmers show the highest projected growth across the infusion therapy landscape. Their value stems from consistent procedure utilization, performance requirements in emergency and operative care and the willingness of providers to invest in warming capabilities that reduce complications. Transfusion device demand also stays stable due to dependable procedure volumes. Unlike NLCs and IV sets, these devices face fewer pricing pressures from GPOs because they are more specialized and harder to substitute. This combination of clinical need and technology-driven ASPs makes them stand out among the fastest growing product groups.
How to apply these insights in strategy
Manufacturers can align with faster-growing categories by prioritizing evidence-backed safety claims, workflow efficiency and digital connectivity. For pumps, investment in cybersecurity, analytics and smart drug libraries strengthens value in replacement cycles. In consumables, clearer positioning around reflux reduction, infection control and DEHP-free materials improves competitiveness. Alternate care channels remain an important lever because device pricing is less constrained than in hospital GPO contracting. In every category, sustained growth depends on balancing innovation with clear clinical and economic justification.
Conclusion
Growth in 2025 is strongest in blood warmers, select smart pump categories and neutral displacement NLCs. Other segments remain essential but expand more slowly due to pricing pressure and product substitution. Understanding which categories accelerate and why helps guide investment, positioning and sales strategy.
Turn market painpoints into opportunities
Explore how procedure trends and competitor positioning create clear openings for industry experts in the market.
